Evidence-Based Principles for Bipolar Disorder Treatment

Baldessarini RJ, Tondo L, Vázquez GH: Pharmacological treatment of adult bipolar disorder. Mol Psychiatry 2019; 24:198–217Crossref, Google Scholar

Bousman CA, Arandjelovic K, Mancuso SG, et al.: Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics 2019; 20:37–47Crossref, Google Scholar

Vajda FJE, Graham JE, Hitchcock AA, et al.: Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6–11Crossref, Google Scholar

Butler M, Urosevic S, Desai P, et al.: Treatment for Bipolar Disorder in Adults: A Systematic Review. AHRQ Comparative Effectiveness Reviews, Report no 18-EHC012-EF. Rockville, MD, Agency for Healthcare Research and Quality, 2018 Google Scholar

Gitlin MJ: Antidepressants in bipolar depression: an enduring controversy. Int J Bipolar Disord 2018; 6:25Google Scholar

Grunze H, Vieta E, Goodwin GM, et al.: The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: acute and long-term treatment of mixed states in bipolar disorder. World J Biol Psychiatry 2018; 19:2–58Crossref, Google Scholar

Harrison PJ, Geddes JR, Tunbridge EM: The emerging neurobiology of bipolar disorder. Trends Neurosci 2018; 41:18–30Google Scholar

Pompili M, Verzura C, Trovini G, et al.: Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders. Expert Opin Drug Saf 2018; 17:197–205Crossref, Google Scholar

Sit DK, McGowan J, Wiltrout C, et al.: Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry 2018; 175:131–139Crossref, Google Scholar

Stern S, Linker S, Vadodaria KC, et al: Prediction of response to drug therapy in psychiatric disorders. Open Biol 2018; 8:180031Google Scholar

Golden JC, Goethe JW, Woolley SB: Complex psychotropic polypharmacy in bipolar disorder across varying mood polarities: a prospective cohort study of 2712 inpatients. J Affect Disord 2017; 221:6–10Crossref, Google Scholar

Liu B, Zhang Y, Fang H, et al.: Efficacy and safety of long-term antidepressant treatment for bipolar disorders: a meta-analysis of randomized controlled trials. J Affect Disord 2017; 223:41–48Crossref, Google Scholar

Pickard BS: Genomics of lithium action and response. Neurotherapeutics 2017; 14:582–587Google Scholar

Samara MT, Goldberg Y, Levine SZ, et al.: Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies. Lancet Psychiatry 2017; 4:859–867Crossref, Google Scholar

Smith KA, Cipriani A: Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord 2017; 19:575–586Crossref, Google Scholar

Song J, Sjölander A, Joas E, et al.: Suicidal behavior during lithium and valproate treatment: a within-individual 8-year prospective study of 50,000 patients with bipolar disorder. Am J Psychiatry 2017; 174:795–802Crossref, Google Scholar

Young RC, Mulsant BH, Sajatovic M, et al: GERI-BD: A randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. Am J Psychiatry 2017; 174:1086–1093Google Scholar

Zhao H, Nyholt DR: Gene-based analyses reveal novel genetic overlap and allelic heterogeneity across five major psychiatric disorders. Hum Genet 2017; 136:263–274Crossref, Google Scholar

Alda M: Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry 2015; 20:661–670Crossref, Google Scholar

Fornaro M, De Berardis D, Koshy AS, et al.: Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review. Neuropsychiatr Dis Treat 2016; 12:719–735Crossref, Google Scholar

Geddes JR, Gardiner A, Rendell J, et al.: Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. Lancet Psychiatry 2016; 3:31–39Crossref, Google Scholar

Henriksen TE, Skrede S, Fasmer OB, et al.: Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disord 2016; 18:221–232Crossref, Google Scholar

Post RM, Leverich GS, Kupka R, et al.: Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. Compr Psychiatry 2016; 66:146–156Crossref, Google Scholar

Wesseloo R, Kamperman AM, Munk-Olsen T, et al.: Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry 2016; 173:117–127Crossref, Google Scholar

Yatham LN, Beaulieu S, Schaffer A, et al.: Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial. Mol Psychiatry 2016; 21:1050–1056Crossref, Google Scholar

Adli M, Whybrow PC, Grof P, et al.: Use of polypharmacy and self-reported mood in outpatients with bipolar disorder. Int J Psychiatry Clin Pract 2005; 9:251–256Crossref, Google Scholar

Alsdorf R, Wyszynski DF: Teratogenicity of sodium valproate. Expert Opin Drug Saf 2005; 4:345–353Crossref, Google Scholar

Altshuler LL, Post RM, Hellemann G, et al.: Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry 2009; 70:450–457Crossref, Google Scholar

Altshuler LL, Suppes T, Black DO, et al: Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry 2006; 163:313–315Google Scholar

Bergink V, Bouvy PF, Vervoort JSP, et al.: Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry 2012; 169:609–615Crossref, Google Scholar

Calabrese JR, Shelton MD, Rapport DJ, et al.: A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162:2152–2161Crossref, Google Scholar

Deligiannidis KM, Byatt N, Freeman MP: Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol 2014; 34:244–255Crossref, Google Scholar

Diav-Citrin O, Shechtman S, Tahover E, et al.: Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry 2014; 171:785–794Crossref, Google Scholar

Geddes JR, Goodwin GM, Rendell J, et al.: Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375:385–395Crossref, Google Scholar

Ghaemi SN, Ostacher MM, El-Mallakh RS, et al.: Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry 2010; 71:372–380Crossref, Google Scholar

Goldberg JF, Brooks JO III, Kurita K, et al.: Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry 2009; 70:155–162Crossref, Google Scholar

Goldberg JF, Burdick KE, Endick CJ: Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 2004; 161:564–566Crossref, Google Scholar

Jentink J, Loane MA, Dolk H, et al.: Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010; 362:2185–2193Crossref, Google Scholar

Kessing LV, Hellmund G, Andersen PK: Predictors of excellent response to lithium: results from a nationwide register-based study. Int Clin Psychopharmacol 2011; 26:323–328Crossref, Google Scholar

Lam DH, Hayward P, Watkins ER, et al.: Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years. Am J Psychiatry 2005; 162:324–329Crossref, Google Scholar

Miklowitz DJ, George EL, Richards JA, et al.: A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 2003; 60:904–912Crossref, Google Scholar

Miklowitz DJ, Otto MW, Frank E, et al.: Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry 2007; 64:419–426Crossref, Google Scholar

Munk-Olsen T, Laursen TM, Mendelson T, et al.: Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry 2009; 66:189–195Crossref, Google Scholar

Newport DJ, Viguera AC, Beach AJ, et al.: Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005; 162:2162–2170Crossref, Google Scholar

Nierenberg AA, Friedman ES, Bowden CL, et al.: Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry 2013; 170:102–110Crossref, Google Scholar

Pacchiarotti I, Bond DJ, Baldessarini RJ, et al.: The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170:1249–1262Crossref, Google Scholar

Popovic D, Reinares M, Goikolea JM, et al.: Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol 2012; 22:339–346Crossref, Google Scholar

Reinares M, Rosa AR, Franco C, et al.: A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. Int J Neuropsychopharmacol 2013; 16:485–496Crossref, Google Scholar

Rosa AR, Fountoulakis K, Siamouli M, et al.: Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. CNS Neurosci Ther 2011; 17:167–177Crossref, Google Scholar

Sachs GS, Nierenberg AA, Calabrese JR, et al.: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356:1711–1722Crossref, Google Scholar

Sidor MM, Macqueen GM: Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry 2011; 72:156–167Crossref, Google Scholar

Swann AC, Bowden CL, Morris D, et al.: Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54:37–42Crossref, Google Scholar

Taylor DM, Cornelius V, Smith L, et al.: Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatr Scand 2014; 130:452–469Crossref, Google Scholar

Tohen M, Vieta E, Calabrese J, et al.: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60:1079–1088Crossref, Google Scholar

Viguera AC, Whitfield T, Baldessarini RJ, et al.: Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817–1824, quiz 1923Crossref, Google Scholar

Yonkers KA, Wisner KL, Stowe Z, et al.: Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608–620Crossref, Google Scholar